N-pyridin-3-yl or N-pyrazin-2-yl carboxamides

A compound according to formula I,

• wherein
• A is CH or N;
• R1 is selected from the group consisting of
• lower alkyl,
• cycloalkyl,
• lower cycloalkylalkyl,
• lower hydroxyalkyl,
• lower alkoxyalkyl,
• lower halogenalkyl,
• lower carbamoylalkyl,
• lower alkylcarbonylaminoalkyl,
• lower phenylalkyl,
• lower heterocyclylalkyl wherein the heterocyclyl group is unsubstituted or substituted by oxo,
• lower heteroarylalkyl wherein the heteroaryl group is unsubstituted or mono- or di-substituted by lower alkyl, and
• phenyl which is unsubstituted or mono- or di-substituted by halogen;
• R2 and R6 independently from each other are hydrogen or halogen;
• R3 and R5 independently from each other are selected from the group consisting of hydrogen, lower alkyl, lower alkoxy, halogen, lower halogenalkyl, lower halogenalkoxy and cyano;
• R4 is selected from the group consisting of hydrogen, lower alkyl, lower alkoxy, halogen, lower halogenalkyl, lower halogenalkoxy, amino, azido and cyano;
• and
• R7 is selected from the group consisting of
• lower alkyl,
• lower hydroxyalkyl, lower alkoxyalkyl,
• lower hydroxyimino-alkyl, lower alkoxyimino-alkyl,
• lower cycloalkyl, said cycloalkyl being unsubstituted or substituted by hydroxy, lower heterocyclyl,
• phenyl, said phenyl being unsubstituted or substituted by one or two groups selected from the group consisting of lower alkyl, hydroxy, lower alkoxy, cyano, lower alkylaminocarbonyl and halogen, and
• heteroaryl, said heteroaryl being unsubstituted or substituted by one or two groups selected from the group consisting of lower alkyl, hydroxy, lower alkoxy, cyano, lower alkylaminocarbonyl and halogen;
• or a pharmaceutically acceptable salt thereof.